U.S. FDA panel narrowly backs Merck’s at-home COVID-19 pill, Health News, ET HealthWorld
By Michael Erman and Manas Mishra A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co’s…

